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article under the CC BY-NC-ND licenseSummary Adult neurogenesis, defined as the generation of new neurons in adulthood, has been
a fascinating discovery in neuroscience, as the continuously replenishing neuronal population pro-
vides a new perspective to understand neuroplasticity. Besides maintaining normal physiological
function, neurogenesis also plays a key role in pathophysiology and symptomatology for psychiat-
ric conditions. In the past decades, extensive effort has been spent on the understanding of the
functional significance of neurogenesis in psychiatric conditions, mechanisms of pharmacological
treatment, and discovery of novel drug candidates for different conditions. In a clinical situation,
however, long-term rehabilitation treatment, in which occupational therapy is the key discipline,
is a valuable, economical, and commonly used treatment alternative to psychotropic medica-
tions. Surprisingly, comparatively few studies have investigated the biological and neurogenic ef-
fects of different psychiatric rehabilitative treatments. To address the possible linkage between
psychiatric rehabilitation and neurogenesis, this review discusses the role of neurogenesis in
schizophrenia, major depression, and anxiety disorders. The review also discusses the potential
neurogenic effect of currently used psychiatric rehabilitation treatments. With a better under-
standing of the biological effect of psychiatric rehabilitation methods and future translational
studies, it is hoped that the therapeutic effect of psychiatric rehabilitation methods could be ex-
plained with a novel perspective. Furthermore, this knowledge will benefit future formulation of
treatmentmethods, especially purposeful activities in occupational therapy, for the treatment of
psychiatric disorders.
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Purposeful activity in psychiatric rehabilitation 43IntroductionGeneration of new neurons in adulthood, a process termed
“adult neurogenesis,” is a specific form of neuroplasticity
that occurs in mammals (Ruan et al., 2014). This biological
process has challenged a dogma in neuroscience that all
neurons are born at the prenatal and early postnatal pe-
riods. The discovery of adult neurogenesis has shed light on
the treatment of neurological conditions, including neuro-
degeneration, with the hope that the newly generated
neurons could replace the lost ones. Interestingly, the
process of neurogenesis is related to the efficacy of psy-
chiatric medications and psychiatric illnesses, and the dis-
covery of the neurogenic effect of antidepressant was one
of the pioneer studies that lead to the intensive investiga-
tion of the role of neurogenesis in psychiatric illnesses
(Malberg, Eisch, Nestler, & Duman, 2000).
Dentate gyrus of the hippocampus and subventricular zone
are the brain regions demonstrating neurogenesis. Because
the hippocampus is recognized by its importance in learning,
memory, and emotional regulation, the downregulation of
neurogenesis in the dentate gyrus may cause dysfunction in
these aspects (Ruan et al.). Recent studies have suggested
that hippocampal neurogenesis is essential for regulating the
hypothalamicepituitaryeadrenal gland axis, which in turn
modulates physiological response to stress (Snyder, Soumier,
Brewer, Pickel, & Cameron, 2011). Because stress is a com-
mon risk factor for various psychiatric illnesses, altered
(usually suppressed) neurogenesis would increase the
vulnerability topsychiatric illnesses andmaycontribute to the
cognitive and emotional signs and symptoms of the diseases.
Basic research studies have demonstrated that neuro-
genesis could be regulated by environmental stimulation or
individual activity (Fabel & Kempermann, 2008). Physical ac-
tivity, environmental enrichment, learning, and reduction in
social stress areproven tobeproneurogenic and could reverse
the related behavioural disturbances. When comparing the
abovementioned stimulation or activity with psychiatric
rehabilitation, a number of commonalities could be observed.
For example, providing sensory stimulation for patients in a
rehabilitation program is similar to the multisensory stimula-
tion delivered by enriched environment (Yang, Zhou, Chung,
Li-Tsang, & Fong, 2013); physical exercise is known to pro-
mote both cognition and emotion; stress, regardless of the
origins, is a well-known risk factor of psychiatric illnesses.
These suggest that neurogenicmodalities are common among
psychiatric rehabilitation treatments, and the patients may
be benefited through the regulation of neurogenesis. This
review will discuss research findings on regulation of neuro-
genesis bynonpharmacologicalmethods,whichmayprovide a
novel perspective to explain the effectiveness of psychiatric
rehabilitation.
Neurogenesis and psychiatric disorders
Depressive disorders
Depressive disorder is one of the leading causes of disability.
The exact pathophysiology, however, still remains obscure.
From the current understanding, risk factors of depressive
disorder would alternate the availability of differentmonoamines and neurotrophic factors (Krishnan & Nestler,
2008), and subsequently induce pathological changes on
both macroscopic (volume of grey/white matter) and micro-
scopic (cellular and subcellular) structures. Such changes lead
to the signs and symptoms of depression. In contrast to the
hypothetical pathology, antidepressant treatment would
reverse the shortage of monoamine/neurotrophic factors
thereby reversing the impairment. About a decade ago, the
proneurogenic properties of antidepressants were discovered
(Malberg et al., 2000) and this led to the proposal of neuro-
genesis hypothesis, which suggests that the impairment in
patients with depression is caused by the disruption in neu-
rogenesis. This hypothesis fuelled the studies that examined
whether disrupted neurogenesis is the key mechanism un-
derlying depression.
Clinical and laboratory findings suggested that neuro-
genesis is involved in depressive disorder. While antidepres-
sant treatmentsareusually found tobeproneurogenic, stress,
which is widely accepted as a risk factor of depression (Lau
et al., 2011), is usually found to suppress neurogenesis. The
opposite effects of antidepressants and stress on neuro-
genesis have been tested in various animal depressionmodels
and the occurrence of depression-like behaviourwas found to
be associated with neurogenesis (DeCarolis & Eisch, 2010).
Because the hippocampus is a key component of the limbic
system, it is not surprising that the new-born neurons are
commonly assumed to take part in mood regulation (Ruan
et al., 2014). To understand the causal role of neurogenesis
in depression, several experimental techniques that suppress
neurogenesis were developed, including X-irradiation, anti-
mitotic drugs, and transgenic animals, which are used in
ablation of neurogenesis and to study the effect of
neurogenesis-suppressing drugs (Ruan et al.). In the study by
Santarelli et al. (2003), after blocking neurogenesis with X-
irradiation, the anxiety level of mice did not decrease even
after treatment with antidepressants. In another study,
blocking hippocampal neurogenesis was found to prevent the
therapeutic effect of antidepressants or psychotropic medi-
cation treatment (Jiang et al., 2005). Furthermore, after
blocking neurogenesis, animals showed a slower recovery
afterexposure tomoderate stress, anddemonstratedchanges
in behavioural phenotypes including increased depression-
like behaviour and anhedonia (Snyder et al., 2011).
Similar to other psychiatric disorders, depressive disor-
der has a complex and elusive pathophysiology. Neuro-
genesis is unlikely to be the sole mechanism underlying the
disease, whereas other cofactors such as stress and neu-
roinflammation are potential players in the pathology. For
example, when animals were subjected to neurogenesis
suppression without exposure to stress, no behavioural
despair was found (David et al., 2009). Nevertheless, the
neurogenesis hypothesis provides a novel point of view on
the biology of depression, and an increasing number of
preclinical research suggests the linkage between neuro-
genesis and depression, but clinical evidence is needed to
further confirm the association.Schizophrenia
The first study that investigated neurogenesis in schizo-
phrenia examined postmortem brain sample from
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pal cell proliferation was found to be suppressed in the
diseased samples (Reif et al., 2006), which was 60% lower
when compared with a control group. Although Reif et al.
only studied cell proliferation and not the other processes
of neurogenesis, their results demonstrated that deficits of
neurogenesis may be a pathological feature of schizo-
phrenia. To simulate one of the hypothetical causes of
schizophrenia (prenatal infection), different studies used
animal model with maternal viral infection (e.g., models
using polyriboinosinicepolyribocytidilic acid; Meyer &
Feldon, 2010). Interestingly, behavioural and cognitive
deficits related to the suppressed neurogenesis were found
in the infected offspring (Meyer & Feldon), including pre-
pulse inhibition disruption, decreased attention, and
reduced working memory. The antipsychotic drug, risperi-
done, however, could reverse the behavioural deficit and
increase neurogenesis (Piontkewitz et al., 2012). The
importance of neurogenesis is further supported by other
pharmacological studies. Phencyclidine, a hallucination-
inducing drug that causes schizophrenia-like symptoms in
animal models, was shown to suppress neurogenesis (Liu
et al., 2006). By contrast, antipsychotics, such as cloza-
pine, increased the proliferation of new cells in different
structures of the brain, such as prefrontal cortex, dorsal
striatum, and hippocampus (Halim, Weickert, McClintock,
Weinberger, & Lipska, 2004). Neurogenesis might be
altered in the hippocampi of schizophrenic patients and is
subjected to the regulation of antipsychotics.
The association between schizophrenia and neuro-
genesis was also shown by genetic analysis. A strong linkage
between schizophrenia and gene was initially suggested by
the disruption in the expression of the schizophrenia 1 gene
(DISC1) in a Scottish family (Enomoto et al., 2009). DISC1
regulates cognitive performance, working memory, forma-
tion of the hippocampus, and has significant neuro-
developmental functions that are important for
neurogenesis. Neuronal PAS domain-containing 3 (NPAS3) is
another gene that is related to schizophrenia (Erbel-Sieler
et al., 2004). Transgenic animals with NPAS3 disruption
demonstrated a schizophrenia-like phenotype, including
impaired memory, deformed sensorimotor gating, and so-
cial recognition (Erbel-Sieler et al.). Simultaneously, sup-
pressed neurogenesis in the hippocampus was shown in
these animals (Pieper et al., 2010). Neuregulin 1 (NRG1) is
also reported to be associated with schizophrenia (Law,
Shannon Weickert, Hyde, Kleinman, & Harrison, 2004).
NGR1 participates in synaptogenesis, activity-dependent
plasticity of synapse, expression of excitatory neurotrans-
mitters, and processes of neurogenesis (Law et al., 2004),
and is thus essential for the normal functioning of the
central nervous system (CNS). Disruption of the signalling
pathway of NRG1 results in hypofunction of the N-methyl-D-
aspartate receptor (Hahn et al., 2006), which resembles
the N-methyl-D-aspartate receptor hypofunction hypothesis
of schizophrenia.Anxiety disorders
Anxiety disorder is one of the most common psychiatric
conditions with a lifetime prevalence over 25% (Ruan et al.,2014). Patients with anxiety disorder show exaggerated
reactions to certain stimuli, but these normally would not
impose immediate threats. Because the response may root
at conditioning, blocking of hippocampal neurogenesis was
suggested to be one of the mechanisms responsible for this
category of disorder.
When it was proven that selective serotonin reuptake
inhibitors could promote neurogenesis (Malberg et al.,
2000), anxiety disorders were suggested to be associated
with neurogenesis because antidepressants are used clini-
cally to treat anxiety disorders, and the aforementioned
speculation was confirmed later (Santarelli et al., 2003).
After blocking neurogenesis, the anxiolytic effect of
fluoxetine was abolished in a novelty suppressed feeding
test. A similar result was found for HU-210, a synthetic
cannabinoid (Jiang et al., 2005): the anxiolytic effect could
only be found in animals with intact neurogenesis. Pre-
gabalin, another class of anticonvulsant drug for general-
ized anxiety disorder, could increase neurogenesis and
prevent depression-like behaviour in animals (Valente
et al., 2012).
Available evidence suggests that among different anxi-
ety disorders, post-traumatic stress disorder (PTSD) is
related to neurogenesis. Previous studies have shown that
patients with PTSD had a reduction in hippocampal volume,
which had an impact on their declarative verbal memory
(Bremner, Elzinga, Schmahl, & Vermetten, 2008). Inter-
estingly, increase in hippocampal volume was reported in
patients with PTSD who received phenytoin (antiepileptic
drug) treatment (Bremner et al.). In addition, the brain-
derived neurotrophic factor signalling pathway, which
regulates neurogenesis, was disrupted in patients with
PTSD (Kaplan, Vasterling, & Vedak, 2010). A preclinical
study showed that animal models of PTSD, induced by
inescapable electric shock, exhibited a physiological
arousal response associated with suppressed hippocampal
neurogenesis (Kikuchi et al., 2008). Recently, neurogenesis
in an animal model of generalized anxiety disorder was
studied and it was found to be suppressed as expected (Dias
et al., 2014).
Regarding the mechanisms, it is possible that the new
neurons may be required in pattern separation, which is the
ability to differentiate highly similar stimulus or experi-
ences. Patients with anxiety disorders may have dysfunc-
tions in pattern separation, and thus could not differentiate
between dangerous and safe cues. Because animal studies
showed that an increase in neurogenesis would benefit
pattern separation (Aimone, Deng, & Gage, 2011; Winocur,
Wojtowicz, & Tannock, 2015), further studies are needed to
test whether the failure in pattern separation is the key
issue in anxiety disorders.Psychiatric rehabilitation and potential
association with neurogenesis
Psychiatric rehabilitation plays an essential role in disease
management for improving functioning and reducing reho-
spitalization rate of the affected individuals. As discussed
earlier, neurogenesis could be regulated by various activity-
based modalities, including enriched environment, physical
exercise, and learning (Brown et al., 2003). Interestingly,
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usually incorporates activities that are related to the
aforementioned modalities. In this section, we will discuss
the potential neurogenic effect of psychiatric rehabilitative
methods, which could alleviate the psychiatric signs and
symptoms.
Enriched physical and social environment
The robust neurogenic effect of enriched environment was
identified two decades ago (Kempermann, Kuhn, & Gage,
1997). It was later shown that the neurogenic effect is
due to the positive influence of the enriched environment
on promoting survival of new-born neurons by suppressing
apoptosis (cell suicide). A typical enriched environmental
setup consists of a living environment with various stimu-
lations including a larger cage; tunnel system, which is
frequently changed; toys; and housing with larger groups of
animals. The environment was suggested to provide multi-
sensory stimulations, social interaction, and equipment for
physical activity. Although the effect of the whole envi-
ronment is strong, specific studies on the separate com-
ponents (i.e., social, different sensory, and physical
activities) are still missing.
Similar to enriched environment, rehabilitation of psy-
chiatric patients was thought to be benefited by situating
patients in the community, which is full of different types
of physical stimulations, social interaction, and novelty.
Assertive community treatment, a rehabilitation treatment
that places patients in the community, is given to schizo-
phrenic patients who are at risk of repeated hospitalization
or are homeless. When the patient is discharged from the
institution, mental health professionals provide continuous
and intensive support to schizophrenia patients and their
support network, such as families, employers, and friends,
so as to help them to adapt to their community life. With
professionals’ assistance, the patients are needed to face
different tasks such as maintaining medication regime,
housing, finance, or issues that are valued by the patients
(Kreyenbuhl, Buchanan, Dickerson, & Dixon, 2010). Com-
munity rehabilitation through assertive community treat-
ment can effectively reduce hospitalization and homeless
rates (Bustillo, Lauriello, Horan, & Keith, 2001), which
echoes with the findings in animal studies that enriched
environment reduces functioning deficit in schizophrenia
models (McOmish et al., 2008).
Physical exercise and activity
Voluntary physical activity is a well-known inducer of hip-
pocampal neurogenesis (Brown et al., 2003). The activity is
usually delivered by placing a running wheel inside the cage
of animals, as voluntary running was found to be endoge-
nously rewarding for the laboratory rodent. Physical activ-
ity has recently been proven to improve cognitive function
and benefit mental health (Bowes, Dawson, Jepson, &
McCabe, 2013), while the promotion of neurogenesis may
be the key factor underlying the benefits. Apart from
cognition, exercising may act as a diversion from negative
thoughts, so as to master new skills, improve social con-
tacts, or may have physiological effects on patients’ CNS(National Collaborating Centre for Mental Health [UK],
2010).
While involving both physical and mental activities,
supported employment (SE; Kreyenbuhl et al., 2010) or
productive activities (Nakamae, Yotsumoto, Tatsumi, &
Hashimoto, 2014) could include activities that are mean-
ingful to the patient. SE is given to patients with schizo-
phrenia who wish to be employed and the individual
placement and support model is the most widely
researched model. Individually tailored job development,
job search, ongoing job supports, and integration of voca-
tional and mental health services are provided and patients
receiving SE can gain further competitive employment and
extended work hours (Kreyenbuhl et al., 2010). In addition,
patients receiving SE did not show increased stress, exac-
erbation of symptoms, or other negative symptoms due to
taking up a worker role.
Learning and cognitive challenges
Because learning is regarded as a primary function of hip-
pocampus, the findings on adult neurogenesis suggested
that learning may be regulated via hippocampal neuro-
genesis (Deng, Aimone, & Gage, 2010). Some evidence
support the roles of new neurons in learning and memory,
but the effect of learning on neurogenesis remains unclear.
When compared with enriched environment and physical
activity, there is less concrete evidence to support the
neurogenic role of learning. Some studies showed that
isolated learning stimuli was neurogenic by promoting the
survival of neurons (Gould, Beylin, Tanapat, Reeves, &
Shors, 1999). However, because learning is usually intro-
duced in a complex environment with different contexts,
its presentation may be embedded in the context with
other stimulus. Thus, studies on causal relationship be-
tween learning and neurogenesis are usually interfered by
confounders (Ehninger & Kempermann, 2006).
Although the direct causal effect needs to be further
confirmed, learning is a commonly adopted treatment
strategy for psychiatric patients. The lasting beneficial ef-
fect implies the structural modification of the CNS and
probably neurogenesis. Usual treatment methods utilizing
learning include cognitive remediation therapy, cognitive
behavioural therapy, problem-solving therapy, and behav-
ioural activation. These methods enable patients to learn
new skills to reduce the impact exerted by the diseases (De
Silva, Cooper, Li, Lund, & Patel, 2013), and even induce
improvement in cognitive functions.
Management of psychosocial stress
Stress is well accepted as a negative regulator of neuro-
genesis (Alonso et al., 2004), and in cases of severe stress,
the effect could even be seen in acute situations (e.g.,
within a few hours). In animal experiments, psychosocial
stress is usually used to study the neurogenic effect of
stress, including predator odour, social isolation, uncon-
trollable foot shocks, and social defeat (Blanchard,
McKittrick, & Blanchard, 2001). Interestingly, the use of
psychosocial stress in animal studies is comparable with the
living environment of human beings, in which the social
46 J.S.-C. Cheung et al.environment is a major source of stress. It is possible that
therapies that tackle social stress would influence the pa-
tient’s neurogenesis.
To reduce social stress, emphasis is usually put on the
family relationship because it is a key social environment
for psychiatric patients. For example, family members and
patients are educated in aspects including illness educa-
tion, crisis intervention, emotional support, and training for
ways to cope with illness symptoms. Some studies reported
that these measures could increase medical adherence,
reduce psychiatric symptoms, reduce level of stress
perceived by the individuals, and reduce rehospitalization
rate (Kreyenbuhl et al., 2010; Wong, Li-Tsang, & Siu, 2014).
The key objectives of modifying the social environment are
to solve interpersonal problems and provide social support.
Animal models demonstrated alteration of neurogenesis
when the experimental animals were subjected to chronic
stress, but social support from conspecies (delivered by
housing in the same cage) was found to normalize neuro-
genesis (Westenbroek, Den Boer, Veenhuis, & Ter Horst,
2004).
Conclusion
Psychiatric rehabilitation, especially those with activity
components, is an important intervention for people
suffering from chronic psychiatric diseases, although the
neurobiological effect may be underestimated. The dis-
covery of neurogenesis provides a novel perspective to
support the effectiveness and efficacy of psychiatric reha-
bilitation and occupational therapy. Future translations
between the basic science studies and clinical situation will
benefit the development of more effective treatment
methods (e.g., purposeful activities in occupational ther-
apy) for psychiatric disorders.
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